• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[术后早期丝裂霉素C灌注:时机与方法?]

[Early postoperative mitomycin C instillation: when and how?].

作者信息

Traxer Olivier, Gattegno Bernard

机构信息

Service d'Urologie, Hôpital Tenon, Paris, France.

出版信息

Prog Urol. 2004 Apr;14(2):249-51.

PMID:15217151
Abstract

The rationale for intravesical chemotherapy in the treatment of superficial bladder tumours is based on the knowledge of their natural history, particularly the propensity of a majority of tumours to relapses, while only a small proportion of these tumours present a risk of progression. The objective of intravesical chemotherapy is to prevent tumour implantation on the site of resection and to eliminate any residual disease responsible for recurrences; this treatment therefore constitutes "chemoprophylaxis". The objective of this technical note is to recall the practical modalities of early postoperative mitomycin C instillation with particular emphasis on two technical points.

摘要

膀胱内化疗用于治疗浅表性膀胱肿瘤的理论依据基于对其自然病史的了解,特别是大多数肿瘤有复发倾向,而只有一小部分这些肿瘤存在进展风险。膀胱内化疗的目的是防止肿瘤种植在切除部位,并消除任何导致复发的残留病灶;因此这种治疗构成“化学预防”。本技术说明的目的是回顾术后早期丝裂霉素C灌注的实际操作方式,特别强调两个技术要点。

相似文献

1
[Early postoperative mitomycin C instillation: when and how?].[术后早期丝裂霉素C灌注:时机与方法?]
Prog Urol. 2004 Apr;14(2):249-51.
2
Risk of post-operative intravesical mitomycin C instillation following transurethral bladder tumor resection.经尿道膀胱肿瘤切除术后膀胱内灌注丝裂霉素C的风险
Can J Urol. 2006 Dec;13(6):3317-20.
3
[Practical impact of pharmacologic and clinical data on early post-operative instillation of mitomycin C].[丝裂霉素C术后早期滴注的药理学及临床数据的实际影响]
Prog Urol. 2002 Feb;12(1):118-23.
4
Immediate administration of intravesical mitomycin C after tumour resection for superficial bladder cancer.
BJU Int. 2006 Jul;98(1):232-3. doi: 10.1111/j.1464-410X.2006.06357_6.x.
5
Increasing medical staff safety by using a closed system for intravesical instillation of mitomycin C.通过使用封闭系统进行膀胱内灌注丝裂霉素 C 来提高医护人员的安全性。
Urology. 2010 Sep;76(3):649-51. doi: 10.1016/j.urology.2010.02.058. Epub 2010 May 20.
6
Intravesical mitomycin C for superficial transitional cell carcinoma.膀胱内注射丝裂霉素C治疗浅表性移行细胞癌。
Expert Rev Anticancer Ther. 2006 Aug;6(8):1273-82. doi: 10.1586/14737140.6.8.1273.
7
[Management of non invasive bladder cancers. T1Ga urothelial cell carcinoma: benefit of immediate post operative instillation?].
Prog Urol. 2010 Mar;20 Suppl 1:S46-9. doi: 10.1016/S1166-7087(10)70026-9.
8
Increasing patient comfort by optimized postoperative administration of intravesical mitomycin C.通过优化膀胱内丝裂霉素C的术后给药提高患者舒适度。
BJU Int. 2008 Dec;102(11):1556-9. doi: 10.1111/j.1464-410X.2008.07898.x. Epub 2008 Aug 6.
9
Chemo-prevention in superficial bladder cancer using mitomycin C: a survey of the practice patterns of British urologists.使用丝裂霉素C对浅表性膀胱癌进行化学预防:英国泌尿外科医生的实践模式调查
BJU Int. 2006 Apr;97(4):716-9. doi: 10.1111/j.1464-410X.2006.05970.x.
10
Immediate administration of intravesical mitomycin C after tumour resection for superficial bladder cancer.浅表性膀胱癌肿瘤切除术后立即膀胱内灌注丝裂霉素C
BJU Int. 2006 Mar;97(3):509-12. doi: 10.1111/j.1464-410X.2006.05965.x.